FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174769504> ?p ?o ?g. }

• W3174769504 abstract "The objective of the study was to investigate the levels of plasma exosome-derived fragile site-associated tumor suppressor (FATS) and evaluate its prognostic predictive ability in ovarian cancer (OC) patients. Exosome-rich fractions were isolated from the plasma of 90 patients with OC enrolled in this study. The levels of plasma exosome-derived FATS were detected by ELISA. The levels of exosome-derived FATS in OC patients were significantly lower as compared to the healthy controls (P < 0.001). The levels of plasma exosome-derived FATS were higher in OC patients with low grade (1/2), and Federation International of Gynecology and Obstetrics (FIGO) Stages I/II than those in high grade (3/4) and Stages III/IV of the disease (p = 0.003; p < 0.001), respectively. The levels of plasma exosome-derived FATS were significantly higher in OC patients with no lymph node metastasis or no ascites as compared to those with lymph node metastasis or ascites, respectively (both p < 0.001). The levels of plasma exosome-derived FATS were higher in OC patients having CA-125 below 35 U/ml as compared to those with CA-125 greater than 35 U/ml (p < 0.001). Among all enrolled OC patients, both 5-DFS and 5-OS were shorter in patients with lower plasma exosome-derived FATS levels than those with higher levels (both p < 0.001). The area under the receiver operating characteristic curve of plasma exosome-derived FATS was 0.85 (95% CI: 0.76-0.91) for 5-DFS and 0.91 (95% CI: 0.83-0.96) for 5-OS prediction in patients with OC. Plasma exosome-derived FATS levels in OC patients were significantly downregulated. Low levels of plasma exosome-derived FATS had a significant relationship with FIGO Stages III/IV, high grade, ascites, higher levels of CA-125, lymph node metastasis, and prognosis of OC patients. Thus, our findings may provide insights for the development of a new strategy OC treatment." @default.
• W3174769504 created "2021-07-05" @default.
• W3174769504 creator A5018974469 @default.
• W3174769504 creator A5027835055 @default.
• W3174769504 creator A5035289755 @default.
• W3174769504 creator A5048826252 @default.
• W3174769504 creator A5055433405 @default.
• W3174769504 creator A5082018758 @default.
• W3174769504 creator A5084581495 @default.
• W3174769504 creator A5089949894 @default.
• W3174769504 date "2021-09-07" @default.
• W3174769504 modified "2023-09-25" @default.
• W3174769504 title "Plasma exosome-derived fragile-site associated tumor suppressor is a powerful predictor of prognosis in patients with ovarian cancer" @default.
• W3174769504 cites W1784590253 @default.
• W3174769504 cites W2029744253 @default.
• W3174769504 cites W225412619 @default.
• W3174769504 cites W2602359212 @default.
• W3174769504 cites W2902272929 @default.
• W3174769504 cites W2939486934 @default.
• W3174769504 cites W2952849134 @default.
• W3174769504 cites W2976880272 @default.
• W3174769504 cites W2995803952 @default.
• W3174769504 cites W2998582467 @default.
• W3174769504 cites W2998729876 @default.
• W3174769504 cites W2999925385 @default.
• W3174769504 cites W3091869292 @default.
• W3174769504 cites W3093266512 @default.
• W3174769504 cites W3101110233 @default.
• W3174769504 cites W3109202473 @default.
• W3174769504 cites W3125183387 @default.
• W3174769504 cites W3130389575 @default.
• W3174769504 cites W3134535951 @default.
• W3174769504 cites W3153817696 @default.
• W3174769504 cites W3157060700 @default.
• W3174769504 cites W3160802415 @default.
• W3174769504 cites W3160987595 @default.
• W3174769504 cites W3162975920 @default.
• W3174769504 cites W3163358397 @default.
• W3174769504 doi "https://doi.org/10.17305/bjbms.2021.6404" @default.
• W3174769504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34491890" @default.
• W3174769504 hasPublicationYear "2021" @default.
• W3174769504 type Work @default.
• W3174769504 sameAs 3174769504 @default.
• W3174769504 citedByCount "3" @default.
• W3174769504 countsByYear W31747695042021 @default.
• W3174769504 countsByYear W31747695042022 @default.
• W3174769504 crossrefType "journal-article" @default.
• W3174769504 hasAuthorship W3174769504A5018974469 @default.
• W3174769504 hasAuthorship W3174769504A5027835055 @default.
• W3174769504 hasAuthorship W3174769504A5035289755 @default.
• W3174769504 hasAuthorship W3174769504A5048826252 @default.
• W3174769504 hasAuthorship W3174769504A5055433405 @default.
• W3174769504 hasAuthorship W3174769504A5082018758 @default.
• W3174769504 hasAuthorship W3174769504A5084581495 @default.
• W3174769504 hasAuthorship W3174769504A5089949894 @default.
• W3174769504 hasBestOaLocation W31747695041 @default.
• W3174769504 hasConcept C104317684 @default.
• W3174769504 hasConcept C121608353 @default.
• W3174769504 hasConcept C126322002 @default.
• W3174769504 hasConcept C134018914 @default.
• W3174769504 hasConcept C145059251 @default.
• W3174769504 hasConcept C185592680 @default.
• W3174769504 hasConcept C20518536 @default.
• W3174769504 hasConcept C2779013556 @default.
• W3174769504 hasConcept C2780427987 @default.
• W3174769504 hasConcept C2780496750 @default.
• W3174769504 hasConcept C2780849966 @default.
• W3174769504 hasConcept C2781261824 @default.
• W3174769504 hasConcept C55493867 @default.
• W3174769504 hasConcept C71924100 @default.
• W3174769504 hasConcept C90924648 @default.
• W3174769504 hasConceptScore W3174769504C104317684 @default.
• W3174769504 hasConceptScore W3174769504C121608353 @default.
• W3174769504 hasConceptScore W3174769504C126322002 @default.
• W3174769504 hasConceptScore W3174769504C134018914 @default.
• W3174769504 hasConceptScore W3174769504C145059251 @default.
• W3174769504 hasConceptScore W3174769504C185592680 @default.
• W3174769504 hasConceptScore W3174769504C20518536 @default.
• W3174769504 hasConceptScore W3174769504C2779013556 @default.
• W3174769504 hasConceptScore W3174769504C2780427987 @default.
• W3174769504 hasConceptScore W3174769504C2780496750 @default.
• W3174769504 hasConceptScore W3174769504C2780849966 @default.
• W3174769504 hasConceptScore W3174769504C2781261824 @default.
• W3174769504 hasConceptScore W3174769504C55493867 @default.
• W3174769504 hasConceptScore W3174769504C71924100 @default.
• W3174769504 hasConceptScore W3174769504C90924648 @default.
• W3174769504 hasFunder F4320331087 @default.
• W3174769504 hasLocation W31747695041 @default.
• W3174769504 hasLocation W31747695042 @default.
• W3174769504 hasLocation W31747695043 @default.
• W3174769504 hasLocation W31747695044 @default.
• W3174769504 hasOpenAccess W3174769504 @default.
• W3174769504 hasPrimaryLocation W31747695041 @default.
• W3174769504 hasRelatedWork W1966504330 @default.
• W3174769504 hasRelatedWork W1979139803 @default.
• W3174769504 hasRelatedWork W2030889776 @default.
• W3174769504 hasRelatedWork W2037631372 @default.
• W3174769504 hasRelatedWork W2040058909 @default.
• W3174769504 hasRelatedWork W2132898409 @default.
• W3174769504 hasRelatedWork W2562792972 @default.

• next